T-cell add-back depleted of host alloreactive cells (investigational product for haploidentical PBSC transplant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-cell add-back depleted of host alloreactive cells (investigational product for haploidentical PBSC transplant), covering 2013-06-20 to 2013-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [Phase 1, Phase 2]